[Clinical Trial Results]: Positive clinical trial data often leads to increased investor confidence and a higher stock price. Negative results can significantly decrease the stock price.

[Regulatory Approvals]: Approval of a drug or therapy by regulatory bodies like the FDA is a major catalyst for stock price increases. Delay or rejection impacts negatively.

[Market Sentiment]: Overall market trends and investor risk appetite can influence the price. Positive market conditions might lift the stock, while negative conditions depress it.

[Competition]: The emergence of competing products or therapies can decrease the market share potential and impact stock price negatively. Lack of competition provides an advantage.

[Financial Performance]: Revenue, profitability, and cash flow all play a role. Strong financials attract investors, while weak financials deter them.

[Partnerships and Collaborations]: Forming partnerships with other pharmaceutical companies can provide resources and expertise, increasing investor confidence. Breaking partnerships would have the opposite effect.

[News and Events]: Major announcements, media coverage, and industry conferences can all affect stock price.